Apyx Medical (APYX) Return on Capital Employed (2011 - 2026)
Apyx Medical's (APYX) quarterly Return on Capital Employed came in at 7.68% in Q1 2026, up 2116.0% YoY from 0.35% in Q1 2025, and up 39.54% on a QoQ basis from 12.7% in Q4 2025.
Apyx Medical (APYX) Return on Capital Employed (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has 16 years of Return on Capital Employed data on file, last reported at 7.68% in Q1 2026.
- Quarterly Return on Capital Employed rose 2116.0% year-over-year to 7.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.68% (up 2116.0% YoY) and the FY2025 annual result came in at 11.82%, up 1891.0% from the prior year.
- Return on Capital Employed rose to 7.68% in Q1 2026, from 12.7% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 7.68% in Q1 2026 to a low of 65.17% in Q1 2023.
- A 5-year average of 33.94% and a median of 34.39% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 3647 bps — and 2024, when it jumped 3682 bps.
- Tracing APYX's Return on Capital Employed over 5 years: stood at 56.54% in 2022, then soared by 46 bps to 30.49% in 2023, then dropped by 19 bps to 36.2% in 2024, then soared by 65 bps to 12.7% in 2025, then soared by 40 bps to 7.68% in 2026.
- The last three Return on Capital Employed figures came in at 7.68% (Q1 2026), 12.7% (Q4 2025), and 20.31% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | Apyx Medical | 136.15 Mn | 108.54 Mn | 8.87 Mn | -6.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.71% |
| Mar 31, 2026 | -7.68% |
| Dec 31, 2025 | -12.70% |
| Sep 30, 2025 | -20.31% |
| Jun 30, 2025 | -25.32% |
| Mar 31, 2025 | -28.84% |
| Dec 31, 2024 | -36.20% |
| Sep 30, 2024 | -40.32% |
| Jun 30, 2024 | -39.32% |
| Mar 31, 2024 | -28.35% |
| Dec 31, 2023 | -30.49% |
| Sep 30, 2023 | -34.39% |
| Jun 30, 2023 | -45.74% |
| Mar 31, 2023 | -65.17% |
| Dec 31, 2022 | -56.54% |
| Sep 30, 2022 | -41.84% |
| Jun 30, 2022 | -35.10% |
| Mar 31, 2022 | -28.71% |
| Dec 31, 2021 | -26.25% |
| Sep 30, 2021 | -25.99% |